Plain-English translation of NCT06106945 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Multiple Myeloma research guide →Phase 1/2 — A combined trial that checks safety and dosing while also starting to look at whether the treatment works.
This study is testing a new drug called for treating multiple myeloma — a blood cancer — in patients who have already tried other treatments. Researchers want to see if works better when given alone or when combined with other cancer medicines. The trial will look at whether the medication is safe, how your body handles it, and whether it helps control your disease.
Multiple myeloma is a serious cancer, and many patients eventually stop responding to standard treatments. This medication is being tested because early research suggests it may help patients whose cancer has come back or become resistant to other drugs.
You likely qualify if…
You likely don't qualify if…
You will visit the study clinic regularly for check-ups, blood tests, and to receive the medication — either as a single drug or combined with other standard cancer medicines, depending on which group you join. The study has different phases: first, researchers find the right dose for the medication, then they test whether it works. Your visits may become less frequent over time as the study continues, and you'll be monitored closely for any side effects.
AI-generated summary from trial data · Sep 2, 2026 · Not medical advice
United States